Infrequent Dialysis: A New Paradigm for Hemodialysis Initiation

Seminars in Dialysis

Volumn 26, Issue 6, 2013, Pages 720-727

  Rhee, Connie M ^a   Unruh, Mark ^b   Chen, Jing ^c   Kovesdy, Csaba P ^d,e   Zager, Phillip ^b,f   Kalantar Zadeh, Kamyar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^c FUDAN UNIVERSITY   (China)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f Dialysis Clinic Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL PRACTICE; GLOMERULUS FILTRATION RATE; HUMAN; METHODOLOGY; MORTALITY; PATIENT SELECTION; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; TREATMENT OUTCOME;

GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84887817079     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12133     Document Type: Article

References (63)

1. US Renal Data System, USRDS 2012 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012
2. Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K: Patterns and predictors of early mortality in incident hemodialysis patients: new insights. Am J Nephrol 35(6):548-558, 2012.
3. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy: National Kidney Foundation. Am J Kidney Dis 30(3 Suppl 2):S67-S136, 1997.
4. Canaud B: Residual renal function: the delicate balance between benefits and risks. Nephrol Dial Transplant 23(6):1801-1805, 2008.
5. Chandna SM, Farrington K: Residual renal function: considerations on its importance and preservation in dialysis patients. Semin Dial 17(3):196-201, 2004.
6. Vilar E, Farrington K: Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24(5):487-494, 2011.
7. Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J: Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study. Am J Kidney Dis 56(2):348-358, 2010.
8. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62(3):1046-1053, 2002.
9. Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, Nolph KD, Pollock CA, Prowant B, Farrell PC: The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 37(4):598-604, 1991.
10. Vilar E, Wellsted D, Chandna SM, Greenwood RN, Farrington K: Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24(8):2502-2510, 2009.
11. Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48(Suppl 1):S2-S90, 2006
12. Couchoud C, Kooman J, Finne P, Leivestad T, Stojceva-Taneva O, Ponikvar JB, Collart F, Kramar R, de Francisco A, Jager KJ: From registry data collection to international comparisons: examples of haemodialysis duration and frequency. Nephrol Dial Transplant 24(1):217-224, 2009.
13. Hanson JA, Hulbert-Shearon TE, Ojo AO, Port FK, Wolfe RA, Agodoa LY, Daugirdas JT: Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol 19(6):625-633, 1999.
14. Japanese Society for Dialysis Therapy: An Overview of Regular Dialysis Treatment in Japan as of December 31, 1997. Tokyo: Bunkyo-ku, 1997:266.
15. Haghighi AN, Broumand B, D'Amico M, Locatelli F, Ritz E: The epidemiology of end-stage renal disease in Iran in an international perspective. Nephrol Dial Transplant 17(1):28-32, 2002.
16. Elamin S, Abu-Aisha H: Reaching target hemoglobin level and having a functioning arteriovenous fistula significantly improve one year survival in twice weekly hemodialysis. Arab J Nephrol Transplant 5(2):81-86, 2012.
17. Lin X, Yan Y, Ni Z, Gu L, Zhu M, Dai H, Zhang W, Qian J: Clinical outcome of twice-weekly hemodialysis patients in shanghai. Blood Purif 33(1-3):66-72, 2012.
18. Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM, Tsai TJ, Wu KD: Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology (Carlton) 14(1):59-64, 2009.
19. Daugirdas JT, Ing TS: Chronic Hemodialysis Prescription: A Urea Kinetic Approach; in Handbook of Dialysis, Chapter 6. Boston: Little, Brown, 1994:99-103.
20. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347(25):2010-2019, 2002.
21. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305(20):1176-1181, 1981.
22. Blagg CR: The early history of dialysis for chronic renal failure in the United States: a view from Seattle. Am J Kidney Dis 49(3):482-496, 2007.
23. Scribner BH, Cole JJ, Ahmad S, Blagg CR: Why thrice weekly dialysis? Hemodial Int 8(2):188-192, 2004.
24. Shaldon S: Experience to date with home hemodialysis. In: Scribner BH (ed.). Proceedings of the Working Conference on Chronic Dialysis. Seattle, WA: University of Washington, 1964:66-69
25. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363(24):2287-2300, 2010.
26. Danovitch GM, Bourgoignie J, Bricker NS: Reversibility of the "salt-losing" tendency of chronic renal failure. N Engl J Med 296(1):14-19, 1977.
27. Feinfeld DA, Danovitch GM: Factors affecting urine volume in chronic renal failure. Am J Kidney Dis 10(3):231-235, 1987.
28. Yeh BP, Tomko DJ, Stacy WK, Bear ES, Haden HT, Falls WF Jr: Factors influencing sodium and water excretion in uremic man. Kidney Int 7(2):103-110, 1975.
29. McKane W, Chandna SM, Tattersall JE, Greenwood RN, Farrington K: Identical decline of residual renal function in high-flux biocompatible hemodialysis and CAPD. Kidney Int 61(1):256-265, 2002.
30. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11(3):556-564, 2000.
31. Van Stone JC: The effect of dialyzer membrane and etiology of kidney disease on the preservation of residual renal function in chronic hemodialysis patients. ASAIO J 41(3):M713-M716, 1995.
32. van Olden RW, van Acker BA, Koomen GC, Krediet RT, Arisz L: Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrol Dial Transplant 10(12):2274-2280, 1995.
33. Rottembourg J: Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int Suppl 40:S106-S110, 1993.
34. Babb AL, Ahmad S, Bergstrom J, Scribner BH: The middle molecule hypothesis in perspective. Am J Kidney Dis 1(1):46-50, 1981.
35. Bargman JM, Golper TA: The importance of residual renal function for patients on dialysis. Nephrol Dial Transplant 20(4):671-673, 2005.
36. Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, Van der Wall Bake AW, Van der Sande FM, Leunissen KM: Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study. Nephrol Dial Transplant 18(4):797-803, 2003.
37. Bargman JM, Thorpe KE, Churchill DN: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12(10):2158-2162, 2001.
38. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13(5):1307-1320, 2002.
39. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15(4):1061-1070, 2004.
40. Suda T, Hiroshige K, Ohta T, Watanabe Y, Iwamoto M, Kanegae K, Ohtani A, Nakashima Y: The contribution of residual renal function to overall nutritional status in chronic haemodialysis patients. Nephrol Dial Transplant 15(3):396-401, 2000.
41. Szeto CC, Lai KN, Wong TY, Law MC, Leung CB, Yu AW, Li PK: Independent effects of residual renal function and dialysis adequacy on nutritional status and patient outcome in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 34(6):1056-1064, 1999.
42. Wang AY, Sea MM, Ip R, Law MC, Chow KM, Lui SF, Li PK, Woo J: Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 12(11):2450-2457, 2001.
43. Wang AY, Woo J, Sea MM, Law MC, Lui SF, Li PK: Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications? Am J Kidney Dis 43(4):712-720, 2004.
44. Wang M, You L, Li H, Lin Y, Zhang Z, Hao C, Chen J: Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function. Clin J Am Soc Nephrol 8(1):116-125, 2013
45. Morduchowicz G, Winkler J, Zabludowki JR, Boner G: Effects of residual renal function in hemodialysis patients. Int Urol Nephrol 26:125-131, 1994.
46. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, Lui SF, Sanderson JE: A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 62:639-647, 2002.
47. Agrawal A, Saran R, Nolph KD: Continuum and integration of pre-dialysis care and dialysis modalities. Perit Dial Int 19(Suppl 2):S276-S280, 1999.
48. Mehrotra R, Nolph KD, Gotch F: Early initiation of chronic dialysis: role of incremental dialysis. Perit Dial Int 17(5):426-430, 1997.
49. Golper TA: Incremental dialysis. J Am Soc Nephrol 9(12 Suppl):S107-S111, 1998.
50. Keshaviah PR, Emerson PF, Nolph KD: Timely initiation of dialysis: a urea kinetic approach. Am J Kidney Dis 33(2):344-348, 1999.
51. Locatelli F, Andrulli S, Pontoriero G, Di Filippo S, Bigi MC: Supplemented low-protein diet and once-weekly hemodialysis. Am J Kidney Dis 24(2):192-204, 1994.
52. Stankuviene A, Ziginskiene E, Kuzminskis V, Bumblyte IA: Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998-2005. Medicina (Kaunas) 46(8):516-521, 2010.
53. Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS: Effect of frequent hemodialysis on residual kidney function. Kidney Int 83(5):949-958, 2013.
54. Molnar MZ, Ojo AO, Bunnapradist S, Kovesdy CP, Kalantar-Zadeh K: Timing of dialysis initiation in transplant-naive and failed transplant patients. Nat Rev Nephrol 8(5):284-292, 2012.
55. Galland R, Traeger J, Arkouche W, Delawari E, Fouque D: Short daily hemodialysis and nutritional status. Am J Kidney Dis 37(1 Suppl 2):S95-S98, 2001.
56. Supasyndh O, Satirapoj B, Seenamngoen S, Yongsiri S, Choovichian P, Vanichakarn S: Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6. J Med Assoc Thai 92(5):624-631, 2009.
57. Fagugli RM, Pasini P, Quintaliani G, Pasticci F, Ciao G, Cicconi B, Ricciardi D, Santirosi PV, Buoncristiani E, Timio F, Valente F, Buoncristiani U: Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol Dial Transplant 18(11):2332-2338, 2003.
58. Burton JO, Jefferies HJ, Selby NM, McIntyre CW: Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol 4(5):914-920, 2009.
59. Chazot C, Jean G: The advantages and challenges of increasing the duration and frequency of maintenance dialysis sessions. Nat Clin Pract Nephrol 5(1):34-44, 2009.
60. Foley RN, Gilbertson DT, Murray T, Collins AJ: Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 365(12):1099-1107, 2011.
61. Zhang H, Schaubel DE, Kalbfleisch JD, Bragg-Gresham JL, Robinson BM, Pisoni RL, Canaud B, Jadoul M, Akiba T, Saito A, Port FK, Saran R: Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int 81(11):1108-1115, 2012.
62. Hatamizadeh P, Fonarow GC, Budoff MJ, Darabian S, Kovesdy CP, Kalantar-Zadeh K: Cardiorenal syndrome: pathophysiology and potential targets for clinical management. Nat Rev Nephrol 9(2):99-111, 2013.
63. Casino FG: The grey line of dialysis initiation: as early as possible that is, by the incremental modality. G Ital Nefrol 27(6):574-583, 2010.